2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Gastric Cancer
Cancer research in the realm of gastric cancer has witnessed significant strides in recent years. Innovations in early detection methods, such as advanced imaging technologies and biomarker identification, have revolutionized diagnosis, enabling timely interventions. Targeted therapies, tailored to individual tumor profiles, have emerged as promising avenues, offering more precise and effective treatment options while minimizing side effects. Additionally, immunotherapy has sparked excitement, harnessing the body's immune system to combat cancer cells. Research efforts continue to unravel the intricate molecular mechanisms underlying gastric cancer progression, paving the way for novel therapeutic approaches. Collaborative initiatives between scientists, clinicians, and pharmaceutical companies drive progress towards personalized treatment strategies, ultimately aiming to improve patient outcomes and survival rates in this challenging disease landscape.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China